This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lado-Abeal, J. Articles by Trainer, P. J. Search for Related Content PubMed PubMed Citation Articles by Lado-Abeal, J. Articles by Trainer, P. J.

Menstrual Abnormalities in Women with Cushing’s Disease Are Correlated with Hypercortisolemia Rather Than Raised Circulating Androgen Levels

Department of Endocrinology, St. Bartholomew’s Hospital (J.R.-A., J.D.C.N.-P., L.A.P., A.B.G., G.M.B., P.J.T.), London, United Kingdom EC1A 7BE; and the Department of Endocrinology and Nutrition, Hospital Xeral de Galicia (J.L.-A.), Santiago de Compostela, Spain

Address all correspondence and requests for reprints to: Dr. P. J. Trainer, Department of Endocrinology, St. Bartholomew’s Hospital, London, United Kingdom EC1A 7BE. E-mail: p.j.trainer{at}mds.qmw.ac.uk

Menstrual irregularity is a common complaint at presentation in women with Cushing’s syndrome, although the etiology has been little studied. We have assessed 45 female patients (median age, 32 yr; range, 16–41 yr) with newly diagnosed pituitary-dependent Cushing’s syndrome. Patients were subdivided into 4 groups according to the duration of their menstrual cycle: normal cycles (NC; 26–30 days), oligomenorrhea (OL; 31–120 days), amenorrhea (AM; >120 days), and polymenorrhea (PM; <26 days). Blood was taken at 0900 h for measurement of LH, FSH, PRL, testosterone, androstenedione, dehydroepiandrosterone sulfate, estradiol (E₂), sex hormone-binding globulin (SHBG), and ACTH; cortisol was sampled at 0900, 1800, and 2400 h. The LH and FSH responses to 100 µg GnRH were analyzed in 23 patients. Statistical analysis was performed using the nonparametric Mann-Whitney U and Spearman tests.

Only 9 patients had NC (20%), 14 had OL (31.1%), 15 had AM (33.3%), and 4 had PM (8.8%), whereas 3 had variable cycles (6.7%). By group, AM patients had lower serum E₂ levels (median, 110 pmol/L) than OL patients (225 pmol/L; P < 0.05) or NC patients (279 pmol/L; P < 0.05), and higher serum cortisol levels at 0900 h (800 vs. 602 and 580 nmol/L, respectively; P < 0.05) and 1800 h (816 vs. 557 and 523 nmol/L, respectively; P < 0.05) and higher mean values from 6 samples obtained through the day (753 vs. 491 and 459 nmol/L, respectively; P < 0.05). For the whole group of patients there was a negative correlation between serum E₂ and cortisol at 0900 h (r = -0.50; P < 0.01) and 1800 h (r = -0.56; P < 0.01) and with mean cortisol (r = -0.46; P < 0.05). No significant correlation was found between any serum androgen and E₂ or cortisol. The LH response to GnRH was normal in 43.5% of the patients, exaggerated in 52.1%, and decreased in 4.4%, but there were no significant differences among the menstrual groups. No differences were found in any other parameter.

In summary, in our study 80% of patients with Cushing’s syndrome had menstrual irregularity, and this was most closely related to serum cortisol rather than to circulating androgens. Patients with AM had higher levels of cortisol and lower levels of E₂, while the GnRH response was either normal or exaggerated. Our data suggest that the menstrual irregularity in Cushing’s disease appears to be the result of hypercortisolemic inhibition of gonadotropin release acting at a hypothalamic level, rather than raised circulating androgen levels.

This article has been cited by other articles:

				Z Karaca, F Tanriverdi, K Unluhizarci, and F Kelestimur Pregnancy and pituitary disorders Eur. J. Endocrinol., March 1, 2010; 162(3): 453 - 475. [Abstract] [Full Text] [PDF]

				A. E. Oakley, K. M. Breen, A. J. Tilbrook, E. R. Wagenmaker, and F. J. Karsch Role of Estradiol in Cortisol-Induced Reduction of Luteinizing Hormone Pulse Frequency Endocrinology, June 1, 2009; 150(6): 2775 - 2782. [Abstract] [Full Text] [PDF]

				C. B d'Alva, G. Abiven-Lepage, V. Viallon, L. Groussin, M. A. Dugue, X. Bertagna, and J. Bertherat Sex steroids in androgen-secreting adrenocortical tumors: clinical and hormonal features in comparison with non-tumoral causes of androgen excess Eur. J. Endocrinol., November 1, 2008; 159(5): 641 - 647. [Abstract] [Full Text] [PDF]

				L. Tauchmanova, R. Pivonello, M. C. De Martino, A. Rusciano, M. De Leo, C. Ruosi, C. Mainolfi, G. Lombardi, M. Salvatore, and A. Colao Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism Eur. J. Endocrinol., September 1, 2007; 157(3): 359 - 366. [Abstract] [Full Text] [PDF]

				V. Castillo, D. Giacomini, M. Paez-Pereda, J. Stalla, M. Labeur, M. Theodoropoulou, F. Holsboer, A. B. Grossman, G. K. Stalla, and E. Arzt Retinoic Acid as a Novel Medical Therapy for Cushing's Disease in Dogs Endocrinology, September 1, 2006; 147(9): 4438 - 4444. [Abstract] [Full Text] [PDF]

				L. Tauchmanova, R. Pivonello, C. Di Somma, R. Rossi, M. C. De Martino, L. Camera, M. Klain, M. Salvatore, G. Lombardi, and A. Colao Bone Demineralization and Vertebral Fractures in Endogenous Cortisol Excess: Role of Disease Etiology and Gonadal Status J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1779 - 1784. [Abstract] [Full Text] [PDF]

				J. R. Lindsay and L. K. Nieman The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment Endocr. Rev., October 1, 2005; 26(6): 775 - 799. [Abstract] [Full Text] [PDF]

				A.-M. Bao, A. Hestiantoro, E. J. W. Van Someren, D. F. Swaab, and J.-N. Zhou Colocalization of corticotropin-releasing hormone and oestrogen receptor-{alpha} in the paraventricular nucleus of the hypothalamus in mood disorders Brain, June 1, 2005; 128(6): 1301 - 1313. [Abstract] [Full Text] [PDF]

				G. Arnaldi, A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, G. A. Fava, J. W. Findling, R. C. Gaillard, A. B. Grossman, et al. Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5593 - 5602. [Abstract] [Full Text] [PDF]

				F. P. Giraldi, M. Moro, and F. Cavagnini Gender-Related Differences in the Presentation and Course of Cushing's Disease J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1554 - 1558. [Abstract] [Full Text] [PDF]

				S G Pasoto, B B Mendonca, and E Bonfa Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations Lupus, March 1, 2002; 11(3): 175 - 180. [Abstract] [PDF]

				J. Lado-Abeal, J. D. Veldhuis, and R. L. Norman Glucose Relays Information Regarding Nutritional Status to the Neural Circuits That Control the Somatotropic, Corticotropic, and Gonadotropic Axes in Adult Male Rhesus Macaques Endocrinology, February 1, 2002; 143(2): 403 - 410. [Abstract] [Full Text] [PDF]